Showing results (131-140 of 1,083) with videos related to

Sort By:
Pageof 109
Expert Opinion on Investigational Drugs|May 13, 2020
Selatogrel, a novel P2Y12 inhibitor: a review of the pharmacology and clinical developmentRocco P Milluzzo, Gabriele A Franchina, Davide Capodanno, et al.
Expert Opinion on Drug Safety|September 19, 2018
Gender differences on benefits and risks associated with oral antithrombotic medications for coronary artery diseaseSara Romano, Sergio Buccheri, Roxana Mehran, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 2, 2025
Chronic Coronary Syndrome and New-Onset Atrial Fibrillation or Venous Thromboembolism: How Best to Manage Antithrombotic Therapy StrategiesAndrea Rubboli, Dominick J Angiolillo, Cecilia Becattini, et al.
Expert Opinion on Drug Safety|November 12, 2020
Safety and efficacy of P2Y12 inhibitor monotherapy in patients undergoing percutaneous coronary interventionsMattia Galli, Davide Capodanno, Felicita Andreotti, et al.
Cardiovascular Diagnosis and Therapy|December 1, 2018
Diabetes and antiplatelet therapy: from bench to bedsideJose R Rivas Rios, Francesco Franchi, Fabiana Rollini, et al.
Revista Espanola De Cardiologia|December 25, 2004
[Predictors of mortality following rescue percutaneous intervention]Pilar Jiménez-Quevedo, Manel Sabaté, Dominick J Angiolillo, et al.
Journal of the American College of Cardiology|March 13, 2010
Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapyDominick J Angiolillo, Esther Bernardo, Davide Capodanno, et al.
The International Journal of Cardiovascular Imaging|June 2, 2007
Angiographic and 3D intravascular ultrasound assessment of overlapping bare metal stent and three different formulations of drug-eluting stents in patients with diabetes mellitusRen Kawaguchi, Manel Sabate, Dominick J Angiolillo, et al.
Pageof 109